NCT03087266

Brief Summary

Thirty-eight periodontitis- and diabetes-affected subjects will be randomly allocated to non surgical periodontal treatment with either Full-Mouth Approach (FM-SRP) or Quadrant approach (Q-SRP). Patients will be seen one day and three months (study completion) after treatment. The 24 hours appointment will be occurring after the entire completion of the FM-SRP or the first quadrant of the Q-SRP. In the latter group other sessions of treatment will be performed within the following 3 weeks. At baseline, 24 hours and three months, anthropometric, inflammatory and endothelial parameters will be collected. Periodontal parameters will be checked at baseline and at three months. Main outcome of the study is the level of C-reactive protein 24 hours after treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 22, 2017

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

November 4, 2020

Status Verified

November 1, 2020

Enrollment Period

4.4 years

First QC Date

March 7, 2017

Last Update Submit

November 3, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Levels C-Reactive Protein

    Changes in C reactive protein (CRP). Unit of measure: mg/L

    Baseline, 24 hours and 3 months after treatment

Secondary Outcomes (15)

  • Full Mouth Plaque Score (FMPS)

    Baseline and 3 months after treatment

  • Full Mouth Bleeding Score (FMBS)

    Baseline and 3 months after treatment

  • Pocket probing depth (PPD)

    Baseline and 3 months after treatment

  • Clinical attachment level (CAL)

    Baseline and 3 months after treatment

  • Recession of the gingival margin (REC)

    Baseline and 3 months after treatment

  • +10 more secondary outcomes

Study Arms (2)

Full- Mouth Scaling and Root Planing

EXPERIMENTAL

FM-SRP Non-surgical periodontal treatment will be performed in all dentition within 24 hours.

Procedure: FM-SRP

Quadrant Scaling and Root Planing

ACTIVE COMPARATOR

Q-SRP Non-surgical periodontal treatment will be performed in all dentition subdivided in four appointments. Each appointment will be performed with one week interval. In each appointment only a "quadrant" of the dentition will be instrumented.

Procedure: Q-SRP

Interventions

FM-SRPPROCEDURE

Non surgical periodontal treatment performed in all dentition within 1-2 appointments in a 24 hour time frame.

Full- Mouth Scaling and Root Planing
Q-SRPPROCEDURE

Non surgical periodontal treatment performed in 4 sessions comprising of a quadrant (1/4) of the dentition each. Performed in 3 weeks time frame.

Quadrant Scaling and Root Planing

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients affected by Periodontal disease
  • % of periodontal pockets of the entire dentition
  • % bleeding on probing of the entire dentition
  • documented radiographic bone loss
  • Diagnosis of Diabetes Type 2 as measured through international standards

You may not qualify if:

  • age younger than 18 years and older than 80 years
  • pregnant or lactating females
  • females using contraceptive methods
  • need of antibiotic coverage for periodontal treatment
  • previous periodontal treatment in the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Pisa

Pisa, 56126, Italy

Location

Related Publications (1)

  • Graziani F, Gennai S, Marruganti C, Peric M, Ghiadoni L, Marhl U, Petrini M. Acute-phase response following one-stage full-mouth versus quadrant non-surgical periodontal treatment in subjects with comorbid type 2 diabetes: A randomized clinical trial. J Clin Periodontol. 2023 Apr;50(4):487-499. doi: 10.1111/jcpe.13760. Epub 2023 Jan 22.

MeSH Terms

Conditions

PeriodontitisDiabetes Mellitus

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Filippo Graziani, DDS, MClinDent, PhD

    University of Pisa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: single-centre randomized controlled clinical trial with a 3- month follow-up
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Periodontology

Study Record Dates

First Submitted

March 7, 2017

First Posted

March 22, 2017

Study Start

June 1, 2016

Primary Completion

November 1, 2020

Study Completion

November 1, 2020

Last Updated

November 4, 2020

Record last verified: 2020-11

Locations